Pharmacogenetics and Drug Metabolism of Newer Antidepressant Agents
J Clin Psychiatry 55:38-45, DeVane,C.L., 1994
Hyponatremia in Neurologic Patients: Consequences and Approaches to Treatment
The Neurologist 12:117-126, Diringer,M.N. &Zazulia,A., 2006
Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005
Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000
Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
Elevated Carbamazepine Levels Associated with Diltiazem Use
Neurol 42:937-938, Shaughnessy,A.F.&Mosley,M.R., 1992
Interactions Between Calcium Channel Blockers and the Anticonvulsants Carbamazepine and Phenytoin
Neurol 41:740-742, Bahls,F.H.,et al, 1991
Reduced Felodipine Bioavailability in Pts Taking Anticonvulsants
Lancet 2:480-482, Capewell,S.,et al, 1988
Verapamil Potentiates Carbamazephine Neurotoxicity:A Clinically Important Inhibitory Interaction
Lancet 1:700-703, Macphee,G.A.,et al, 1986
Carbamazepine Neurotoxicity Precipitated by Dilitiazem
BMJ 292:1170-1171, Brodie,M.J.,et al, 1986
Effect of Carbamazepine on Coumadin Metabolism
Ann Neurol 13:691-692, Massey,E.W., 1983
Interaction Between Carbamazepine & Warfarin
BMJ 280:1415-1416, Ross,J.R.Y.,et al, 1980